AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 3,826.2%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 3,826.23% |
Nexalin Technology (NXLIW) | 1,511.27% |
Codere Online Luxembourg SA Warrants (CDROW) | 833.52% |
MMTEC (MTC) | 806.68% |
LENZ Therapeutics (LENZ) | 762.03% |
AdTheorent (ADTHW) | 708.08% |
GeneDx (WGS) | 690.74% |
Bone Biologics Corp Warrants (BBLGW) | 678.4% |
Breeze Holdings Acquisition (BREZW) | 653.77% |
Fitell Corporation Ordinary Shares (FTEL) | 630.92% |
AGBA Acquisition (AGBA) | 629.44% |
Airship AI (AISPW) | 624.64% |
Candel Therapeutics (CADL) | 618.12% |
Corbus Pharmaceuticals (CRBP) | 615.31% |
Solowin Holdings Ordinary Share (SWIN) | 606.48% |
Binah Capital Group, Inc Warrants (BCGWW) | 593.91% |
Palladyne AI (PDYNW) | 563% |
Elevation Oncology (ELEV) | 559.26% |
Spectaire (SPECW) | 551.67% |
Armada Acquisition Corp I Warrant (AACIW) | 550.5% |
Biofrontera Inc Warrants (BFRIW) | 550% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
PHP Ventures Acquisition Corp Warrants (PPHPW) | 530% |
Swvl (SWVL) | 514.38% |
Dave (DAVE) | 502.45% |